Lorazepam | |
---|---|
Esters [] | |
---|---|
Lorazepam acetate | |
Molecular structure via molpic | |
Conformer structure via 3Dmol.js | |
Molecular formula | C16H12Cl2N2O2 |
---|---|
Molecular mass | 335.2 g/mol |
Predicted LogP | 2.4 |
Melting point | 206 °C |
Chirality | racemic |
Identifiers [] | |
---|---|
IUPAC name | 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one |
SMILES | CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl |
InChI | InChI=1S/C16H12Cl2N2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3 |
InChIKey | FJIKWRGCXUCUIG-UHFFFAOYSA-N |
Dosing | |
---|---|
Elimination half-life | 10–12 hours |
Oral [] | |
---|---|
Threshold | 0.3 - 0.5 mg |
Light | 0.5 - 1 mg |
Common | 1 - 2 mg |
Strong | 2 - 3 mg |
Heavy | 3 - 4 mg |
Statistically derived dosages by Sernyl |
Lorazepam
Lorazepam (also known as Lormetazepam, Methyllorazepam, N-Methyllorazepam, Loramet, Noctamid, Lormetazepamum, Chlorotemazepam, Ergocalm, Noctamide or WY-4082) is a substance of the benzodiazepine class.
Chemistry
Lorazepam is typically found in the form of its acetate ester.
Stereochemistry
(RS)-Lorazepam is a racemic mixture of the optical stereoisomers:Stereoisomers [] | |
---|---|
(+)-Lorazepam | (-)-Lorazepam |
Legal status
- Brazil: Lorazepam is a B1 substance.
- Canada: Lorazepam is a Schedule IV substance.
- Germany: Lorazepam is a prescription only/Anlage III substance.
- United States: Lorazepam is a Schedule IV substance.
See also
External links
- Lorazepam (Wikipedia)
- Lorazepam / (+)-Lorazepam / (-)-Lorazepam (Wikidata)
- Lorazepam (DrugBank)
- Lorazepam / (+)-Lorazepam / (-)-Lorazepam (PubChem)
- Lorazepam / (+)-Lorazepam / (-)-Lorazepam (ChEMBL)
- Lorazepam (ChEBI)
- Lorazepam / (+)-Lorazepam / (-)-Lorazepam (Common Chemistry)
- Lorazepam (HMDB)
- Lorazepam (KEGG)
- Lorazepam / (+)-Lorazepam / (-)-Lorazepam (UNII)
- Lorazepam / (+)-Lorazepam / (-)-Lorazepam (EPA DSSTox)